Danimer Scientific, Inc. announced impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported Impairment of long-lived assets of $188,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7512 USD | -4.89% | -2.02% | -26.35% |
05-07 | Transcript : Danimer Scientific, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (DNMR) DANIMER SCIENTIFIC Reports Q1 Revenue $10.2M, vs. Street Est of $10.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.35% | 65.6M | |
+8.41% | 41.81B | |
-20.44% | 21.99B | |
-13.38% | 13.29B | |
-9.15% | 10.12B | |
-7.25% | 9.92B | |
+16.16% | 8.22B | |
+10.42% | 7.03B | |
-23.95% | 5.92B | |
-29.11% | 3.31B |
- Stock Market
- Equities
- DNMR Stock
- News Danimer Scientific, Inc.
- Danimer Scientific, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023